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Abstract. The axonal surface glycoproteins neuron- 
glia cell adhesion molecule (NgCAM) and axonin-1 
promote cell-cell adhesion, neurite outgrowth and fas- 
ciculation, and are involved in growth cone guidance. A 
direct binding between NgCAM and axonin-1 has been 
demonstrated using isolated molecules conjugated to 
the surface of fluorescent microspheres. By expressing 
NgCAM and axonin-1 in myeloma cells and performing 
cell aggregation assays, we found that NgCAM and ax- 
onin-1 cannot bind when present on the surface of dif- 
ferent cells. In contrast, the cocapping of axonin-1 upon 
antibody-induced  capping of NgCAM on the surface of 
CV-1 cells coexpressing NgCAM and axonin-1 and the 
selective chemical cross-linking of the two molecules in 
low density cultures of dorsal root ganglia neurons indi- 
cated a specific and direct binding of axonin-1 and Ng- 
CAM in the plane of the same membrane. Suppression 
of the axonin-1 translation by antisense oligonucle- 
otides prevented neurite outgrowth in dissociated dor- 
sal root ganglia neurons cultured on an NgCAM sub- 
stratum, indicating that neurite outgrowth on NgCAM 
substratum requires axonin-1. Based on these and pre- 
vious results, which implicated NgCAM as the neuronal 
receptor involved in neurite outgrowth on NgCAM 
substratum, we concluded that neurite outgrowth on an 
NgCAM substratum depends on two essential interac- 
tions of growth cone NgCAM: a trans-interaction with 
substratum NgCAM and a cis-interaction with axonin-1 
residing in the same growth cone membrane. 
T 
HE function of the nervous system is based  on a 
highly  intricate  pattern  of  connections  between 
neurons. To reach distant targets,  neurons form 
axons that elongate along prespecified pathways to the ap- 
propriate target area.  Cell surface molecules  and compo- 
nents  of the  extracellular matrix  serve  as  cues  for  di- 
rectional growth of the growth cone (Dodd and Jessell, 
1988; Hynes and Lander, 1992). Sensor molecules on the 
growth cone that recognize  and transduce environmental 
growth signals  include molecules of the  Ig superfamily 
(Rathjen and Jessell,  1991). A  well-characterized  repre- 
sentative of these is the neuron-glia cell adhesion mole- 
cule (NgCAM) I (Grumet and Edelman, 1984; Burgoon et al., 
1991), which is the presumptive avian homologue of L1 
(Rathjen and Schachner, 1984; Moos et al., 1988). NgCAM 
on one cell binds homophilically to NgCAM on another 
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cell  (Grumet and Edelman, 1988). Heterophilic interac- 
tions of NgCAM have been reported with the cell adhe- 
sion molecules axonin-1  (Kuhn et al., 1991), Fll (Brtim- 
mendorf et al., 1993), the proteoglycans 3F8 (Grumet et al., 
1993a), neurocan (Friedlander et al.,  1994), phosphacan 
(Milev et al., 1994), and the extracellular matrix glycopro- 
tein laminin (Grumet et al., 1993b). 
The heterophilic interaction between NgCAM and axo- 
nin-1 had initially been discovered  with isolated NgCAM 
and  axonin-1  conjugated  to  the  surface  of  fluorescent 
polystyrene beads (Kuhn et al., 1991). Studies at the single 
cell  level  had revealed  that NgCAM  and  axonin-1  are 
colocalized  on growth cones of several  neuronal popula- 
tions including dorsal root ganglia (DRG) neurons (Kuhn 
et al., 1991; Stoeckli  et al., 1996), cutaneous and muscle 
sensory neurons (Honig and Kueter, 1995), and commis- 
sural neurons of the spinal cord (Stoeckli and Landmesser, 
1995). Both molecules might therefore have a role as re- 
ceptors  mediating neurite  outgrowth  (Sonderegger and 
Rathjen, 1992). Observations with cultivated DRG neu- 
rons growing on NgCAM substratum indicated that axo- 
nin-1 is required in growth cones for neurite outgrowth 
(Stoeckli  et al., 1996), although NgCAM is generally ac- 
cepted as the major neuronal receptor involved in the in- 
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Moreover, on NgCAM but not on laminin substratum, ax- 
onin-1 and NgCAM were redistributed to the substratum- 
facing membrane of the growth cone. Since a direct inter- 
action of growth cone axonin-1 with substratum NgCAM 
was not required, an interaction of axonin-1 and NgCAM 
in the plane of the growth cone membrane (cis-interac- 
tion) was suggested (Stoeckli et al., 1996). 
The studies presented here provide direct evidence for 
the existence of a cis-interaction between NgCAM and ax- 
onin-1.  Antibody-induced capping  of NgCAM  on  CV-1 
cells expressing both molecules resulted in cocapping of 
axonin-1. Chemical cross-linking experiments with DRG 
neurons cultivated on a laminin substratum without cell- 
cell contacts revealed the existence of NgCAM/axonin-1 
heterodimers in the neuronal membrane. Conversely, Ng- 
CAM and axonin-1 expressed in myeloma cells did not in- 
duce mixed aggregates, indicating that a binding between 
NgCAM and axonin-1 residing in the membranes of dif- 
ferent cells (trans-interaction) was not formed. Since the 
suppression of axonin-1 translation via antisense oligonu- 
cleotides resulted in an inhibition of neurite outgrowth on 
NgCAM  substratum,  we  suggest  that  NgCAM/axonin-1 
dimers  in  the  growth  cone membrane play an  essential 
role in the mechanism of neurite outgrowth promotion. 
Materials and Methods 
Proteins, Antibodies, and Reagents 
Axonin-1 was purified from the ocular vitreous fluid of embryonic day (E) 
14 chicken embryos as described (Ruegg et al., 1989a).  NgCAM was im- 
munoaffinity purified from detergent-solubilized brain membranes of El4 
chicken (Stoeckli et al., 1991), using the mAb 12-I-14E-311,  provided by 
Dr. Fritz G. Rathjen (Max Delbriack-Centrum for Molekulare Medizin, 
Berlin, Germany). Purified NrCAM was provided by Dr. G. Elisabeth 
Pollerberg (Max-Planck-Institute for Developmental Biology, Tiibingen, 
Germany).  Laminin was purchased from  GIBCO  BRL (Gaithersburg, 
MD). Antisera against axonin-1 and NgCAM were raised in rabbits and 
goats (Ruegg et al., 1989a), and Fab fragments were prepared as described 
previously (Stoeekli et al., 1991).  Polyclonal antiserum against Fll was 
provided  by  Dr.  Fritz  G.  Rathjen,  polyclonal  antiserum  against  Nr- 
CAM(Bravo)  by  Dr.  G.  Elisabeth  Pollerberg,  and  the  mAb  2B3-CA 
against NrCAM by Dr. William J. Dreyer (California Institute of Technol- 
ogy,  Pasadena,  CA).  Peroxidase-conjugated anti-mouse Fab  and  goat 
anti-rabbit IgG, and the secondary antibodies for enhanced chemilumi- 
nescence detection, were from Boehringer Mannheim (Mannheim, Ger- 
many).  Affinity-purified rabbit anti-mouse IgG,  FITC-labeled  donkey 
anti-goat IgG, and Texas red-conjugated donkey anti-rabbit IgG were 
purchased from Jackson ImmunoResearch Laboratories  (West  Grove, 
PA). FITC-labeled rabbit anti-goat IgG were from Zymed Laboratories, 
Inc. (South San Francisco, CA). Disuccinimidyl tartarate (DST) was pur- 
chased from Pierce Chemical Co. (Rockford, IL). Dimethylsulfoxide was 
from Merck (Dietikon, Switzerland). PMSF, pepstatin A, leupeptin, apro- 
tinin, and CHAPS were from Sigma Chemical Co. (St. Louis, MO). Triton 
X-100, NP-40,  and  ~-octylglueoside were from Fluka  (Buehs, Switzer- 
land); DAB was from Serva (Heidelberg, Germany); and CNBr-activated 
Sepharose 4B from Pharmacia (Dtibendorf, Switzerland). Reagents for 
enhanced chemiluminescence detection were from Boehringer Mannheim. 
PCR Cloning and Sequencing of the cDNA of NgCAM 
Total RNA was prepared from El4 chicken brain and retina (Han et al., 
1987). Poly(A)-rich RNA was isolated by a passage over an oligo(dT)-cel- 
lulose column (type 3; Collaborative Research, Inc., Bedford, MA). First- 
strand eDNA was transcribed with SuperscriptRNaseH- reverse tran- 
scriptase (GIBCO BRL). 20 I-~g  poly(A)-rich RNA was dissolved in 80 I~1 
diethylpyrocarbonate-treated  H20,  containing  5.5  mM  methylmer- 
curi(II)hydroxide (Johnson Mathey Alfa Products, Karlsruhe, Germany), 
and heated for 4 rain at 94°C  to prevent formation of secondary RNA 
structures. After cooling on ice, the methylmercurihydroxide was neutral- 
ized by addition of 2-mercaptoethanol to a final concentration of 8 raM. 
Transcription was then performed for 1.5 h at 45°C in 50 mM Tris-HCl, 
pH 8.3,  with 3 mM MgCl2, 75  mM KCI, 10 mM DTT,  500  p,M dATP, 
dCTP, dGTP, and dTI'P, 1 U/Ixl RNAsin (Promega, Catalys AG, Wal- 
liseUen, Switzerland), 1 p.M random hexamer primer (Promega) or I00 IJ,  g/ml 
oligo-dTl2.16-  primer  (Promega),  and  20  U/p,I  reverse  transcriptase 
(GIBCO BRL). The eDNA fragments, termed AB1FC-AB16B, AB15F- 
AB10B, AB9F-AB4B, and AB5F-AB2B, were amplified with PCR using 
the oligo-(dT)- or random hexamer-primed first-strand eDNA as a tem- 
plate and conditions that favored strand denaturation. A typical reaction 
mixture contained 0.5 U/ml AmpliTaq DNA Polymerase (Perkin-Elmer 
Corp., Norwalk, CT), 200 I~M of dATP, dGTP, dCTP, and dTTP, 1.0 mM 
of Mg  2÷, 200 nM of each primer, 1/10 of the transcription pool, and 2% 
formamide in a vol of 50 p.l. In a 35-cycle amplification, denaturation was 
performed for 1 min at 950C, annealing for 2 min at 60-70°C (depending 
on the primer pair), and elongation for 3 min at 72°C. 
Primers were synthesized by Microsynth (Balgaeh, Switzerland). Each 
PCR fragment was amplified in three parallel reactions from first-strand 
eDNA originating from three independent RNA pools. The following oli- 
gonucleotides  were  used:  AB1FC:  5'-GCTGAAGCITCCGCCATG- 
GCTCTGCCCCATG-3'  (HindlIl restriction site underlined, start codon 
bold-typed);  AB16B:  5'-GGATCGATCACGGTGACGCTGTGGGT- 
GCC-3'  (ClaI  underlined); AB15F:  5'-CGCCTGCTGCTGCCTCGAG 
ACC-3' (XhoI underlined); AB10B: 5'-GAAGGATCGATCGTCCTG- 
CAGAGC-3'  (ClaI  underlined);  AB9F:  5'-CTCTGCAGGACGATC- 
GATCCTTCG-3'  (ClaI  underlined);  AB4B:  GGAAGCTTACITAC- 
CTATTGTCGACGACTGCGCTCCCCCAC  (Salt  underlined); AB5F: 
TGGGGGAGCGCAGTCGTCGACCAAGC  (Sail underlined); AB2B: 
CCAAGCTTACTTACCTAATCCAGGGGGGGCCCAGCAC  (HindlII 
underlined,  termination codon bold-typed, splice donor  consensus se- 
quence in italics). 
To generate single-strand DNA, each PCR fragment was subcloned 
separately into the pBluescript vector (Stratagene, La Jolla, CA). Each 
fragment was sequenced with Sequenase 2.0 (United States Biochemical 
Corp.,  Cleveland,  OH)  using  the  dideoxy  chain-termination  method 
(Sanger et al.,  1977).  For sequence analysis we used GCG  (version 7, 
Unix; Silicon Graphics Ine., Schlieren, Switzerland). 
Heterologous Expression of NgCAM by Myeloma Cells 
and Analysis of Myeloma Cell Aggregation 
To express NgCAM on the surface of nonadherent cells, we used a my- 
eloma-based expression system that has been applied successfully to the 
production of membrane-bound axonin-1 (Rader et al., 1993). As we have 
reported previously, these cells do not express detectable quantities of L1 
and TAG-l, the presumptive mammalian homologues of NgCAM and ax- 
onin-1. A full-length eDNA clone of NgCAM was constructed with (a) the 
986-bp ABIFC-AB16B fragment using the primer-derived HindIII and an 
internal XmaI site at position 845;  (b) the 678-bp AB15F-AB10B frag- 
ment using the same XmaI and a backward primer-derived silent ClaI site 
at position 1403; (c) the 1,188-bp AB9F-AB4B fragment with the same si- 
lent Cla[ and a silent SalI site at position 2591 in the backward primer; and 
(d) the 1,260-bp  AB5F-AB2B fragment by means of the SalI silent site 
and a HindIII site on AB2B at the very 3' end of the molecule (see Fig. 1). 
The full-length eDNA was then digested with HindIII and cloned into the 
vector pCD4-FvCD3-Ck  (Traunecker  et al., 1991; Rader et al.,  1993)  to 
generate the vector pNgCAM for NgCAM expression in mouse myeloma 
cells. Stable transfectants were obtained by protoplast fusion and selection 
with L-histidinol. After 10 d, the cells were screened for surface NgCAM 
by indirect immunofluorescence. Colonies with a high NgCAM expression 
were expanded and subcloned. 
To analyze the aggregation of NgCAM- and axonin-l-expressing my- 
eloma cells, fluorescent intracellular dyes were used. Myeloma cells were 
incubated in PBS with either 1 mM 2',7'-bis-(2-carboxyethyl)-5-(and 6-) 
earboxyfluorescein acetoxymethyl ester (B-1150;  Molecular Probes, Eu- 
gene, OR) or 7.5 mM 5-(and 6-) carboxynaphtofiuorescein  diacetate (C-654; 
Molecular  Probes)  for 30  min  at  37°C.  Differently stained cells were 
mixed, dissociated by repeated pipetting through a 22-gauge cannula, in- 
cubated for 1 h  at 37°C, and then examined with a fluorescence micro- 
scope (Leitz DMRXE; Leica AG, Glattbrugg, Switzerland) using a com- 
bined FITCO"RITC  filter. For controls, the myeloma cells were preincubated 
for 1 h at 4°C with 250 ~g/ml goat anti-NgCAM Fab. 
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Electroporation and Analysis of Covaspheres Binding 
For  expression of NgCAM  and  axonin-1  in  CV-I(CCL-70;  American 
Type Culture Collection, Rockville, MD) and COS-7 (CRL-1651; Ameri- 
can Type Cultutre Collection) cells, full-length cDNAs of NgCAM and 
axonin-1 (Zuellig et al., 1992) were cloned into the vector pSCT-1 (Rus- 
coni et al., 1990) to generate the vectors pSCT-NgCAM and pSCT-axo- 
nin-1 (Rader et al., 1996),  respectively. Transient transfectants were ob- 
tained by electroporation. 
Binding assays were  performed 2  d  after transfection (Rader  et  al., 
1996). TRITC-labeled fluorescent polystyrene microspheres (Covaspheres, 
nominal diam 0.5 p~m;  Duke Scientific Corp., Palo Alto, CA) were conju- 
gated with NgCAM, axonin-1, and recombinant axonin-1, as previously 
described (Kuhn et al., 1991).  The cells were incubated with NgCAM- or 
axonin-1--conjugated Covaspheres for  1  h  at  37°C,  washed twice  with 
DME containing 5 mg/ml BSA, and fixed in 2% formaldehyde (Fluka) for 
1 h at 37°C. NgCAM- or axonin-l-expressing  cells were visualized by indi- 
rect immunofluorescence using goat antisera against NgCAM or axonin-1, 
respectively, and FITC-conjugated rabbit anti-goat IgG. For quantifica- 
tion, NgCAM- or axonin-l-expressing cells that bound Covaspheres five- 
fold above background were scored as binding cells. A  total of 100 Ng- 
CAM- or axonin-l-expressing cells were counted. Background bindings 
by nonexpressing cells were  2  for NgCAM- and  1 for axonin-l-Cova- 
spheres. 
For  antibody  perturbation  of Covaspheres binding, cells  were  pre- 
incubated for 2 h at 37°C with 250 ixg/ml goat anti-NgCAM or anti-axo- 
nin-1 Fab. 
Transfection, Selection, and Screening of CV-1 Cells 
CV-1 cells were transfected with pSCT-axonin-1 using [N-l-(2,3-dioley- 
loxy)propyl]-  N,N,N,-trimethylammonium  chloride  (synthesized  by  P. 
Ri~edi, Institute of Organic Chemistry, University of Zurich, Switzerland). 
Axonin-1--expressing clones were selected by incubating the transfected 
cells with Dynabeads (DYNAL A.S., Oslo, Norway) coated with poly- 
clonal goat anti-axonin-1  antibodies.  NgCAM-expressing clones and 
NgCAM/axonin-l-expressing  clones  were  obtained  by  cotransfecting 
wild-type- and axonin-1--expressing CV-1 cells, respectively, with pSCT- 
NgCAM  and  pSVneo2.  After  the  selection  with  the  antibiotic  G418 
(GIBCO BRL), NgCAM--expressing cells were isolated with Dyuabeads 
coated  with  polyclonal  anti-NgCAM  antibodies.  The  transfected  cells 
were then analyzed for NgCAM and/or axonin-1 expression by indirect 
immunofluorescence. 
Neurite Outgrowth Assays on NgCAM-expressing 
CV-1 Cells 
CV-1 cells were cultured in dishes coated with 500 ixg/ml poly-D-lysine in 
DME supplemented with 2.5%  FCS and 2.5%  newborn calf serum and 
grown to confluency. DRG were dissected from El0 chick embryos, disso- 
ciated by trypsinization and trituration (Sonderegger et al., 1985; Stoeckli 
et al., 1991).  Cultures were enriched for neurons by preplating on plastic 
for 1 h. The enriched DRG neurons were then plated at low density on the 
CV-1  cells. The  cocultures were  maintained in  DME  supplemented 
with 100  Ixg/ml holo-transferrin (human; Sigma Chemical Co.), 20 ng/ml 
NGF,  10 p~g/ml insulin, 20 ng/ml triiodothyronine, 40 nM progesterone, 
200 ng/ml corticosterone, 200 IxM putrescine and 60 nM sodium selenite, 
10% horse serum, and 5% chicken embryo extract. Where indicated, the 
medium contained 250 ixg/ml anti-NgCAM or anti-axonin-1 Fab. After 20 h 
at 37°C, the ceils were fixed in 2% formaldehyde, 0.1% glutaraldehyde, 
12.5 mM sodium cacodylate, pH 7.2, for 1 h. Neurons were stained with 
the rabbit anti-Fll serum and Texas red-conjugated donkey anti-rabbit 
IgG. Neuronal processes longer than two cell diameters were defined as 
neurites (Venstrom and Reichardt, 1995). 
Cocapping Experiments 
CV-1 cells stably transfected with axonin-1 and NgCAM were cultivated 
to a confluency of 25%. Cells were washed in cold PBS and incubated for 
30 rain at 4°C with 10 p~g/ml monoclonal anti-NgCAM (12-I-14-E 311) or 
anti-axonin-1 (V1F1) antibodies, respectively. To induce capping of Ng- 
CAM or axonin-1, the cells were incubated with affinity-purified rabbit 
anti-mouse IgG (20 Ixg/ml) for 30 rain at 4°C, washed twice in HBSS, and 
incubated for 30 min at 37°C in DME. Thereafter, the cells were washed 
with HBSS containing 0.1% sodium azide and fixed in 2% paraformalde- 
hyde, 0.1% glutaraldehyde, 12.5 mM sodium cacodylate, pH 7.2, for 1 h at 
4°C. The antibody-induced caps were stained with Texas red-conjugated 
donkey anti-rabbit IgG (5 ~g/ml) in 10% (vol/vol) FCS/PBS for 1 h. In 
NgCAM-capped cells,  axonin-1 was  detected  using goat  anti-axonin-1 
Fab (20 p,g/ml). In axonin-l-capped cells, NgCAM was detected with goat 
anti-NgCAM Fab (10 Ixg/ml). Goat Fab were then detected by FITC-con- 
jugated donkey anti-goat IgG (10 p,g/ml).  FITC and Texas red fluores- 
cence  was  detected  with  a  confocal  laser  scanning microscope  (Multi 
Probe 2001TM CLSM; Molecular Dynamics, Sunnyvale, CA), using an ar- 
gon/krypton laser and  the single scanning mode. For  the detection  of 
FITC, the band-pass excitation filter 488DF10 was used in combination 
with  a  510DRLP  primary  beam splitter  and  a  long-pass barrier  filter 
510EPLP. For the detection of Texas red, the band-pass excitation filter 
568DF10 was used in combination with a 488/568 dual dichroic filter as a 
primary beam splitter and a 590EFLP long-pass barrier filter. 
Chemical Cross-linking 
Chemical cross-linking was performed on DRG neurons cultivated in 
100-mm culture dishes coated with laminin. The culture, containing 1x 
106 neurons, was washed in PBS and placed on ice. All subsequent steps 
were  performed  on  ice.  The  cross-linking  reagent  DST  dissolved  in 
DMSO was added to a final concentration of 1 mM. The reaction was al- 
lowed to proceed for 0, 20, and 60 min, and then stopped by the addition 
of glycine (pH 8.0) to a final concentration of 50 raM. After quenching for 
5 min, the cells were lysed for 1 h in 1 m150 mM Tris, pH 7.6, containing 
1% (wt/vol) CHAPS, 0.1% (wt/vol) SDS, 150 mM NaCI, 5 mM EDTA, 10 
p,g/ml leupeptin,  10 }xg/ml aprotinin,  10 Ixg/ml pepstatin A, and  1 mM 
PMSF. Lysates were centrifuged at 12 000 g for 15 min at 4°C. The super- 
natant was transferred to a vial containing 5 Ixl monoclonal anti-axonin-1 
antibody coupled to Sepharose 4B (5 ~g IgG per p~l Sepharose) and incu- 
bated at 4°C for 90 min. Immunoprecipitates were washed four times in 
the lysis buffer, twice in 50 mM Tris (pH 7.6), 0.1%  (wt/vol)  CHAPS, 
0.1% (wt/vol) SDS, and 150 mM NaCI, and once in 50 mM Tris (pH 7.6), 
150 mM NaCI. The protein was eluted in reducing buffer and separated by 
SDS-PAGE using a 5% polyacrylamide gel (Laemmli, 1970). 
Western Blotting 
For Western blot analysis of total cellular proteins, ~106 transfected my- 
eloma, CV-1, or COS-7 cells, 105 DRG neurons, or 250 p.g E14 chicken 
brain protein were washed twice and resuspended in 500 p.l ice-cold PBS. 
The cells were centrifuged at 4°C in an Eppendorf centrifuge at 1,000 rpm, 
resuspended in 500 p.l lysis buffer, and shaken for I  h at 4°C. Cell debris 
was removed by centrifugation for 10 rain at 4°C with 14,000 rpm in an 
Eppendorf centrifuge. The proteins of the supernatant were precipitated 
(Wessel and Fluegge, 1984), resuspended in 50 ixl SDS-containing sample 
buffer, subjected to electrophoresis on a 7.5%  acrylamide gel, and then 
transferred to nitrocellulose. For detection we used: rabbit anti-axonin-1, 
anti-NrCAM, anti-F11, goat anti-NgCAM, and monoclonal anti-NgCAM 
antibody (1 I.Lg/ml  of purified IgG). Secondary antibodies were 0.2 p.g/ml 
anti-rabbit IgG, 0.4 Ixg/ml anti-goat Fab, or 0.4 Ixg/ml anti-mouse Fab 
fragments, all coupled to peroxidase. The chemiluminescence detection 
system from Boehringer Mannheim was used according to the manufac- 
turer's recommendation. Exposure times ranged from 5-30 s. For quanti- 
fication of axonin-1 and NgCAM, 50, 100, 250, 500, 750, and 1,000 pg of 
purified protein were used as standards. Densitometric analysis was car- 
ried out with Image Quant software (version 4.1; Molecular Dynamics). 
For sequential immunodetection with different antibodies on the same 
nitrocellulose, the antibodies bound to the nitrocellulose were removed 
by incubation in TBS containing 50 mM 2-mercaptoethanol and 1% (wt/ 
vol) SDS for 30 min at 25°C. The membrane was washed four times for 15 
min each in TBS, blocked for at least 1 h in 1% blocking reagent, and re- 
probed with another antibody. This procedure allowed the serial applica- 
tion of up to five different antibodies. 
Suppression of Axonin-1 by Antisense Oligonucleotides 
The 5'  proximal axonin-1 antisense phosphorothionate oligonucleotide 
with the sequence 5'-CAGTGCCTCCCATCCTGTGGCTC 3' spanned 
from the nucleotides -10 to  +12, referring to  +1 being the first nucle- 
otide of the translation initiation codon. The 3' proximal antisense phos- 
phorothionate oligonucleotide including the natural stop codon had the 
sequence 5'-GCTACCTGGAGCTCTGATGG-3' (Zuellig et al., 1992). 
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genes. After purification by ion exchange chromatography and gel filtra- 
tion, the oligonucleotides were dissolved in quartz-distilled water in a con- 
centration of 2 mg/ml. Trituration was used to introduce oligonucleotides 
into  DRG  neurons  (Aigner  and  Caroni,  1995). Chick  DRGs  were 
trypsinized for 15 min at 37°C and subjected to 15-20 cycles of trituration 
through a yellow tip (Gilson, Synmedic, Zurich, Switzerland) in 50 ~1 se- 
rum-free defined medium containing the oligonucleotides in the concen- 
trations indicated.  The cells were pelleted by centrifugation for 2 min at 
320  g,  washed  once  in  serum-free medium,  centrifuged  again,  resus- 
pended, and plated. Within a range of 25-100  ~M of axonin-1  antisense 
oligonucleotide, a dose-dependent reduction of axonin-1  was observed. In 
a typical reaction, 100 IxM of each oligonucleotide were applied. The axo- 
nin-1 expression remained reduced for ~24 h, but it was restored thereaf- 
ter. The administration of sense oligonucleotides resulted in a slight re- 
duction of the measured axonin-1 to 92  +-- 6% (mean _  SD, n  =  3) as 
compared with the amounts found in untreated cultures. Similar differ- 
ences between sense oligonucleotide-treated  and untreated control cul- 
tures were also found for Fll and NgCAM. Therefore, we concluded that 
the oligonucleotides were not toxic at the concentrations we used. Cell vi- 
ability  was assessed by dye  exclusion with trypan blue.  Neurons were 
identified by immunocytochemical detection using the neuronal marker 
Fll. 
Neurite lengths were measured 15 h after plating the cells, as described 
previously in detail  (Stoeckli et al.,  1991) using an inverted microscope 
equipped with phase-contrast optics.  A  neurite was defined as a process 
extending from the neuronal cell  soma by >20  Ixm. Only neurites that 
emerged from an isolated neuron (not a clump of cells) and did not make 
contact with other neurites or cells were measured. The longest of all neu- 
rite branches elaborated by a neuron was measured. The percentage of 
neurons with a neurite longer than a given length was plotted vs neurite 
length (Chang et al., 1987). As a characteristic for neurite outgrowth un- 
der a given condition, the neurite length developed by 50% of the neurite- 
bearing neurons (NLs0) was determined (Stoeckli  et al., 1991). 
Results 
Reverse Transcription (RT)-PCR Reveals  NgCAM with 
a Sequence Different from Published  NgCAM 
Reverse transcription (RT)-PCR cloning of the cDNA of 
NgCAM was performed based on three different poly(A)- 
rich RNA pools prepared from E14 chicken brain  and 
retina. PCR primers were designed according to the pub- 
lished sequence (Burgoon et al.,  1991,  1995).  PCR frag- 
ments were subcloned and then sequenced. Where devia- 
tions from the published sequence were found, they were 
confirmed in at least one additional RT-PCR fragment de- 
rived from a different mRNA pool. Reproducible devia- 
tions  from  the  published  sequence  were  confirmed  by 
backward  sequencing.  The sequences  of the  primer  re- 
gions were checked by RT-PCR amplification and sequenc- 
ing of fragments spanning over the primer regions. 
The sequence of the coding region of the PCR-cloned 
NgCAM presented here (Fig. 1) was compared with the 
published NgCAM sequence (Burgoon et al.,  1991, 1995) 
using the program GAP (Needleman and Wunsch, 1970), 
which maximizes the  number of matches  and minimizes 
the number of gaps in an alignment of two complete se- 
quences.  The  identity  of the  nucleotide  sequences  was 
98.5%. Several insertions and deletions of single basepairs 
at various locations throughout the length of the molecule 
resulted in  frameshifts over extended  segments  (under- 
lined in Fig.  1). Thus, the identity between PCR-cloned 
and published NgCAM at the level of the deduced amino 
acid sequence was 93%. A domain-wise comparison dem- 
onstrated that the largest deviations were in the fourth and 
fifth fibronectin type III (FnIII)-like domains that exhib- 
ited an identity of 67.8%  and 74.8%, respectively. Tryp- 
tophan  residues,  which  are  considered characteristic  of 
FnfII domains, but were not present in the published se- 
quence, are  located  at  positions 958  and  1056  of PCR- 
cloned NgCAM. PCR-cloned NgCAM exhibits an amino 
acid identity of 39.7% with NgCAM-related cell adhesion 
molecule (NrCAM)  (Grumet et al., 1991; Kayyem et al., 
1992), the closest relative of NgCAM in the chicken. The 
sequence identity between PCR-cloned NgCAM  and L1 
(Moos et al., 1988), the putative species homologue of the 
mouse, is 49.3%. Pairwise alignment of colinear domains 
showed  that  PCR-cloned  NgCAM  exhibits  a  markedly 
higher sequence similarity to L1  than the published Ng- 
CAM sequence in the region of the FnIII-like domains 4 
and 5 (data not shown). This region had been previously 
discussed to be unusually divergent in the published Ng- 
CAM sequence from the colinear domains of other mem- 
bers  of  the  L1  subgroup  (Brtimmendorf  and  Rathjen, 
1993). 
The relationship between the PCR-cloned NgCAM pre- 
sented here and the published NgCAM  (Burgoon et al., 
1991, 1995) cannot be determined based on the presently 
available data. The two sequences have been derived from 
mRNA of outbred chickens, and a detailed analysis of the 
genomic  representation  of NgCAM  has  not  been  pub- 
lished so far. Several related Ig superfamily cell adhesion 
molecules have been found to be expressed in multiple 
splice variants. The most extensive alternative RNA splic- 
ing  has  been  reported for NCAM  (Cunningham  et  al., 
1987), where variants differing by as little as one codon 
have been found (Moolenaar et al., 1992) and, based on 
RNA  diversity, as many as  192  possibilites for different 
proteins have been calculated  (Barrels et al.,  1992).  In- 
triguingly, multiple splice variants have also been reported 
for NrCAM(Bravo), the closest relative of NgCAM (Kay- 
yem et al., 1992). We have found evidence for at least one 
variant form of NgCAM. Amplification of the cytoplasmic 
domain provided one clone lacking the RSLE sequence. 
This sequence has been previously reported to be variably 
expressed also in human L1 (Hlavin et al., 1991; Reid and 
Hemperly, 1992) and in NrCAM(Bravo) (Kayyem et al., 
1992). Further experimental work, e.g., at the genomic or 
at the mRNA level, will be necessary to clarify the issue of 
possible additional variants of NgCAM. 
NgCAM Expressed by CV-I Cells 
Promotes Neurite Outgrowth in the Presence  of 
Anti-Axonin-1 Antibodies 
Published  results  demonstrated  that  the  neurite  out- 
growth-promoting  effect of brain-derived,  affinity-puri- 
fied NgCAM adsorbed to tissue-culture plastic is not af- 
fected by the presence of polyclonal Fab against axonin-1 
(Kuhn et al.,  1991; Stoeckli et al.,  1996), indicating that a 
heterophilic trans-interaction between  NgCAM  substra- 
tum and growth cone axonin-1 may not be required for 
neurite outgrowth. To investigate the neurite outgrowth- 
promoting activity of NgCAM expressed on the surface 
of a cell rather than adsorbed to tissue-culture plastic, dis- 
sociated  DRG  neurons  were  cultivated  on  a  confluent 
monolayer of CV-1 cells that were stably transfected with 
a  full-length  cDNA  encoding NgCAM.  As  revealed by 
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1  ATGGCTCTC,  CCCCATGGGCTC~CTCCTCCTC,  CT~CT~AGC  CGCCATCACCATTCCCCCGGAGTATC~ACACGATTTCCTGCA~  CCCCC  GAlACtiC  CCCC~C~CTCGT~T  C~C 
1M  ~  L  P  X  a  L  G  L  L  L  t  L  L  L  G  G  P  ~  A  •  I  T  I  P  9  E  Y  G  A  H  D  F  L  Q  P  P  E  ~  T  E  E  P  P  K  Q  L  V  V  F 
151  CCCA~TC-ATC,  ACATCGTCCTCAAATGCGTGGCCACCGGGAACCCCCC  CGTCCAGTACCGATC, GAGC  CGTGAGGATCAGCCC~'~CGTCCC  CGAGGAGCA~~CC~A~A~A~CGC~CG 
51P  S  D  D  I  V  L  K  ~V  A  T  G  N  P  P  V  Q  Y  R  W  S  R  E  D  Q  P  F  v  P  E  E  H  G  G  V  S  V  V  9  G  S  G  T  L  V  I  N  A  T 
I 
301  TTGGCCGC~CAGGGG~C  CGCTGCTTCGCCACCAACGCGTTGGGCACCGCTGTGTCTC  C  CGAGGCCAACGTCATC GCCGAG~C  TC  CG~C~G~CCC~A~C  C  CC 
101  L  A  A  R  L  Q  G  R  F  R  C~  F  A  T  N  A  L  G  T  A  V  S  P  E  A  N  V  I  A  E  N  T  P  Q  W  P  •  •  K  V  T  P  V  E  V  E  E  G  D  P 
451  GT~CCT~TGACCCCCCCGAC-AGCGCT~C  CCCCTAAAATCTATTGGCTCAACAC,  CGACATCGTTCACATCGCTC~TATC~A~C  CT  CTA~CC~CGCCA~AC~ 
151  V  V  L  P  C~  D  P  P  E  S  A  V  P  P  K  I  Y  W  L  N  S  D  I  V  H  I  A  Q  D  E  R  V  S  M  G  Q  D  G  N  b  Y  F  S  N  A  M  V  G  D  S 
IZ 
ABISF  > 
601  CACCC  CC~CTACATC~CACGCTCACTTCCTCGGCCCCCC~ACCA'fCATCCAGAAGGAGC  CCC'fCC-ACCTCCG~CC  C  CA~  ~TC  CCGC~CCC~C~C~CTGCCCCGC~C  CCC  C~C~CCAC  CATC 
201  H  P  D  Y  I  ~  H  A  H  F  L  G  P  R  T  I  I  Q  K  E  P  L  D  L  R  V  A  P  S  N  A  V  R  S  R  R  P  R  L  L  L  P  R  D  P  Q  T  T  T  I 
X 
751  GCCCTCC~GC~GTG~TCGCTC~CCCCACTC  CATC~CGATC~GGCTC~CGGCCCCCTCCC~GGCG'~C~C~CGC~C~C~AG 
251  A  L  R  G  G  S  V  V  L  E  C~  I  A  E  G  L  P  T  P  W  V  R  W  R  R  L  N  G  P  L  P  T  •  A  •  L  •  N  F  N  K  T  L  R  L  I  WIG  V  T  E 
ABI6B  /  I 
901  AGCC-ACGACG~GTACGAATG~TC~GAACGGGAGC~CGGCCAGGG~CACCCACAGCG'fCACCGTGGAGGCCGCCC  ~TA~C  ~GA~C~CC~AGA~C~C 
301  S  D  D  G  E  Y  E  C~  V  A  E  N  G  R  G  T  A  R  G  T  H  S  V  T  V  E  A  A  P  ¥  W  V  R  R  P  Q  S  G  V  F  G  P  G  E  T  A  R  L  D 
1051  GAGGTGG~CCCCGACCCCA~TCCAATGGAGC  ATCAATGGGGTCC CCATCGACG CGCTGCCGGGCGCGGAGCGGCGGTGGCTGCGGGGCGGCGCTTTGGTGCTTCCGGAGCTGC~C  CG~C~CAGCGC~AG~ 
351  E  V  G  G  K  P  R  P  Q  I  Q  W  S  I  N  G  V  P  I  D  •  L  P  G  A  E  R  R  W  L  R  G  G  A  L  V  L  P  E  L  R  P  N  D  S  A  V  L  Q 
IV 
1201  GAGGCGAGGAAc CGC  CACGGCCGCCTATTGGCCAACGCCTTC  C  TGCACGTCGTGGAGCTGC  CGGTC  CGAATGCTGACGGCGGATGACCAGC~TAC~G~CC~C~TC  ~CACTG~G~CC~C~C  C  CCC 
401  E  A  R  N  R  H  G  •  L  L  A  N  A  F  L  H  V  V  E  L  P  V  R  M  L  T  A  D  E  Q  R  Y  E  V  V  E  N  Q  T  V  F  L  H  C~  R  T  F  G  A  P 
--  AB9F  C 
1351  GCGCCAAACGTC GASTGGC TGACCCCCACTTTGGAGCCGG~TCTGCAGGAC~--~-G~CCTTCGTGTTCACCAATGGGAGC  CTT  0  GGCTGAGTGCGGTGCGGGGGGGGGACGG~ACAC  CTGCA~  C  C  ~CG CC~GC 
451  A  P  N  V  E  W  L  T  P  T  L  E  P  A  L  Q  D  D  R  S  F  V  F  T  N  G  S  L  R  L  S  A  V  R  G  G  D  G  G  V  Y  T  ~)  M  A  Q  N  A  H  S 
ABIOB  V 
1501  AACGGCAGCCTCACGGCGCTCCTGGAGGTCAGAGC~CCCACCCGAATTTCGGCCCCCCCCCGAAGCGCCACCGCCAAAAAAGC~`~AGACGGTGACC  TT  TCAC~CGACC  T  T  ~ACCCCGC~ACCCCC~AGCTGCGA~ 
501  N  G  S  L  T  A  L  L  E  V  R  A  P  T  R  I  S  A  P  P  R  S  A  T  A  K  K  G  E  T  V  T  F  H  (~  G  A  T  F  D  P  A  V  T  P  G  E  L  R  W 
A 
VI 
1651  CTGCGGGGGGGGCAGCCGCTGC  CCGACGAC C  C  CCGGTATTCGGTGGCGGC  GGAGACGCTC~ACGGTGTC CAACGTGGACTATGGGGACGAGGGGACCATTCAGTGCCGCGCCTC  CAC  C  CCTCTCGACTCCGCGGA~C  CG~GCGCA~  TC 
L  R  G  G  Q  P  L  P  D  D  P  R  Y  S  V  A  A  E  TL  T  V  S  N  V  D  Y  G  D  E  G  T  I  Q  C~  R  A  S  T  P  L  D  S  A  E  A  E  A  Q  L  551 
1 
1951 GGGCGCTTCGCGGAGCGGCTGACGGTTCCC~GCAGCCATGGACGCCCCCCCTCCCGCTGTCCCCATACC~GG~rCCC~CTTCCGGGTGG~CCGTT~CGC~AC~A~A~ACAGC~CC~CAGCGCCC~CATC~ 
651  (~  R  •  A  •  •  L  T  V  P  G  G  Q  p  W  T  P  P  L  P  L  S  P  Y  G  R  It  F  R  V  V  A  V  N  A  Y  G  R  G  E  H  i  A  P  S  A  P  I  E 
2101  ACC  C  C  C  CC  CGCGGCTC CGGAGCGCAACCCGGGG~TCCATGGGGAGGGCAATGAGAC  CGGCAACCTCGTCATCAC  CTGGGAGCCC CTC  CCC  C  CCCAGGC  CTGG~CGCCCC  ~C~TAC  C  GCGTG  CA~C~C  CA~AG 
701  T  P  P  A  A  P  E  R  N  P  G  G  V  H  G  E  G  N  E  T  G  N  L  V  I  T ~W~  E  P  L  P  P  Q  A  W  N  A  P  W  V  R  Y  R  V  Q  W  R  P  L  E 
2 
2251  GAGCCCGGCGG~CCCTTCGGGGGGGTTCCCG~CGAAAGCACCGTC~CGCCCCC~CCGTC.~CTCCCCCCGTTCAGCCC~CCAGATCCGCGTCCAGGCCGTGAACGGAGCCC.GGAAGGGACCGGAAGCG 
751  E  P  G  G  G  G  P  S  G  G  F  P  W  A  E  S  T  V  D  A  P  P  V  V  V  G  G  L  P  P  F  S  P  ~  Q  I  R  V  Q  A  V  N  G  A  G  K  G  P  E  A 
2401  ACC  C  C  C  C,  GCG'~CCGGCACAGCGGGGAGGAC  CTGC  CGTTC,  GTTTACCCTGAGAAT(]TC~TGGAACTGCTGAACAGCAC,  CAC  CGTGCGCGTCAGATGGACTTTC~CC  CAAAGAGCTGCGC,  C.GGCG~A~TTCC  ~ 
801  T  P  G  V  G  H  S  G  E  D  L  P  L  V  Y  P  E  N  V  G  V  E  L  L  N  S  S  T  V  R  V  R  ~  T  L  G  G  G  P  K  E  L  R  G  R  L  R  G  F  R 
AB5F  S  3 
2551  GTGCTGTATTC~G'I'TTGGGATGGGTGGGGGAG  CGCAGT~C  C  C  C  CC  CGACCCCC CCCAAAT  CCC  C  CAAAGCC  CGGCTGAAGACCCAC C  C  CCATTTCCCCC CGTGGC  TC  TGACAGTGGG~ACGCGCC~GC~ 
851  v  b  Y  W  R  L  G  W  ~  G  E  R  S  R  R  ~  A  P  P  D  P  P  Q  I  P  Q  S  P  A  E  D  P  P  P  F  P  p  V  •  L  T  V  G  G  D  A  R  G  A  L 
AB4B 
2701  CTC~CTGCC~  CCTGGAGCCGTTATCAGC  TG  CGGGTG~F~GGTCTTCAACGGGAGG~CC~CCC  C  CCAGCG~CCCA~CC~CGAGAC  C  C  C  CGA~G~CCC~CCC  CCCGA~AGCTC  CGCG~AC 
901  L  G  G  L  R  P  W  S  R  Y~Q  L  R  V  L  V  F  N  G  R  G  D  G  P  P  S  E  P  I  A  F  E  T  P  E  G  V  P  G  P  P  E  E  L  R  V  E  R  L  D 
2851 GACACCG~CCT~TCCGTc~ATTGGAAA~c~c~GGCATTTAAA~GGAGT~TCACGGGATATGTAcTGAGATACcAGCAG~Tc,GAGCCGGCG~TCGGC~TCCCC~A~C~ACC~CCCC~CCcT~GACC~ 
951  D  T  A  L  S  V  m~W~•  R  P  •  m  L  N  G  V  L  T  G  Y  V  L  R  Y  Q  Q  V  E  P  A  L  Q  L  P  Q  •  A  P  Y  P  P  ~  T  ~  M  A  T  L  R 
4 
3001  GGGCTC~/~3CGCGCTCCCC~CCGG~GCGCGAGCACC~GCGTCC~GGAGCGGCCCCGCCCTGCAGACGGTGC~A~ACGAAACCGGAACCC~CCTCCCCGCTT~GCGCGTT~G~TC~TC~T 
1001  G  L  N  A  R  S  R  Y~_~ R  L  A  L  R  A  S  T  R  V  Q  •  a  P  A  L  Q  T  V  G  S  T  K  P  E  P  •  L  P  A  L  •  R  V  L  V  S  •  V  •  •  D 
3~51~CAC~T~GT~1~CA~CC~ACGACG~G~GTCC~TG~TAj~AC~A~CCG~CG~CCGCGCC~CTC~TACCGT~GGAG~C~C~ 
I051FTVLL~JLVQPQEDDVEFEVQFMNKSTDEPWRTSGRANSSLRRYRLEGLR 
5 
33~CC~AC~C~ACc~GTCC~TTCG~cC~CCGCTCC~G~CG~c~CTGGG~AGC~CC~C~AC~GCAGCCTC~CCACC~CATC~C~GTC 
II01PGTA[]RVQFVGRNRSGENVAFWESEVQTNGTVVRBLVQGFATKGWFIGFV 
3451 AGCTCCGTC~GTGCTCCTTCT~CTCATCCTCCTCATCCTCTGCTTCATCAAACGCAGCAA~CAAGTATT~GGTGAAGGACAAC~GAGGACA~C~CAGGTGGACTCTGA~CGC~CCCA~TGAGACC~AGTA~ 
1151  S  S  V  v  L  L  L  L  I  L  L  l  L  C  F  T  K  R  S  K  G  G  K  Y  S  V  K  D  K  E  D  T  Q  V  D  S  E  A  R  P  M  K  D  E  T  F  G  E  Y  ]% 
3601  T  CG  TTGGAGAG CC~G  CGGAGGAG~GGGTTCGGCTTCGGGTTC  CGGCGC  CGGTTC  CGGTGTC,  GGTT  CTCCC.GGTCC.GGGTCCG,i,  GCGC~C~CA~G~GACAG  C  CT~C~TAC~A~C  AGC  ~ATG  TG  CAGTT  C~TGAG 
1201  N  L  •  S  E  A  E  ~l  K  G  S  A  S  G  S  G  A  G  S  G  V  G  S  P  G  R  GAPBCB2  A  A  ~GS  E  D  S  L  A  G  Y  G  G  S  G  D  V  Q  F  N  E 
5751  GATC-GATCC~CATCGC-GCAGTACCGCGGAC  CCGGAGC  C  C-GACCCGGCAGCTC CGOCCC  TG  CCAGCCCC'~GTC~TC-GGCCCC C  CCTOGATTAG 
1251  D  G  S  F  I  G  Q  Y  R  G  P  G  A  G  P  G  S  S  G  P  A  S  P  C  A  G  P  P  L  D  * 
Figure 1.  Nucleotide and deduced amino acid sequence of RT-PCR-NgCAM.  The open reading frame contains 1,280 amino acids. The 
restriction sites of the cDNA that were used for cloning are boxed. Restriction sites on PCR primers are indicated only when used for 
cloning. Abbreviations for restriction sites are: H, HindlII; X, XmaI; C, ClaI; S, Sail. The signal peptide (1-21) and the transmembrane 
region (1,144--1,166)  are underlined by a thin bar. The sequences used in the PCR primers are marked by arrows. The Ig-like domains 
are numbered from I to VI under the conserved  tryptophans,  and the characteristic  cysteines  are circled. The FnlII-like domains are 
numbered 1-5, and the conserved tryptophans, phenylalanines, and tyrosines are boxed. Amino acids that differ from the published se- 
quence (Burgoon  et al.,  1991,  1995)  are marked with bold letters and underlined with a thick bar. Additional conserved  tryptophans 
that were not in the published sequence were found at the amino acid positions 958 and 1056. The RSLE peptide in the cytoplasmic do- 
main (bold) was not present in one of the clones found in this study. These sequence data are available from EMBL/GenBank/DDBJ 
under accession number Z75013. 
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ing from expression in different  cell lines. Extracts from chicken 
brain membranes (a), chicken  DRG neurons (b),  stably trans- 
fected myeloma (c), transiently  transfected COS-7 (e), and stably 
transfected CV-1 (g) cells, as well as from untransfected myeloma 
(d),  COS-7  (I3, and CV-1  (h)  cells were subjected  to Western 
blotting.  NgCAM  was  visualized  using  a  polyclonal  antibody. 
Each lane contains °°250 Ixg protein. Untransfected myeloma (d), 
COS-7 (f), and CV-1 (h) cells do not express NgCAM.  Double- 
transfected CV-1 cells express axonin-1 (i) and NgCAM (k) at a 
ratio of ~1:2. 
Western blot analysis, the transfected cells expressed re- 
combinant NgCAM with the  characteristic band pattern 
(Fig. 2 g).  15 h  after plating, the cultures were fixed and 
the  neurons  were  stained  for  the  neuronal  marker  Fll 
(Fig. 3). Neurite outgrowth was quantified by counting the 
neurons  with  neurites  longer  than  two  cell  diameters 
(Venstrom  and  Reichardt,  1995).  NgCAM-transfected 
cells, but not the parental untransfected CV-1 cells, stimu- 
lated neurite outgrowth of DRG neurons (Fig. 3; Table I). 
Neurite outgrowth was inhibited by anti-NgCAM but not 
by anti-axonin-1  Fab.  The  polyclonal anti-NgCAM  Fab 
did not perturb neurite outgrowth on a laminin substratum 
at concentrations up to 500 ~g/ml (Kuhn et al., 1991), and 
thus  we concluded  a  toxic effect of this  preparation for 
neurites growing on CV-1 cells to be unlikely. The poly- 
clonal  anti-axonin-1  Fab  had  been  previously  demon- 
strated to completely prevent the heterophilic binding be- 
tween  NgCAM  and  axonin-1  conjugated  to  fluorescent 
microspheres (Kuhn et al., 1991), as well as the homophilic 
trans-binding  of  axonin-1  expressed  by  myeloma  cells 
(Rader et al., 1993).  Based on these characteristics, we as- 
sumed that in the presence of these antibodies, a hetero- 
philic  trans-interaction  between  NgCAM  on  the  CV-1 
cells  and  axonin-1  on  the  growth  cones  could  not  be 
formed.  Thus,  the  result  suggests  that  recombinant  Ng- 
CAM  expressed on  the  surface of CV-1  cells stimulates 
neurite outgrowth without a heterophilic trans-interaction 
with growth cone axonin-1. 
Axonin-l-and NgCAM-expressing Myeloma Cells Do 
Not Form Mixed Aggregates 
To test whether NgCAM and axonin-1 could mediate cell 
aggregation  via  binding  across  the  intercellular  space 
(trans-binding),  NgCAM  and  axonin-1  were  stably  ex- 
pressed in myeloma cells, and the NgCAM- and axonin-1- 
expressing myeloma cells were stained with different fluo- 
rescent intracellular dyes and subjected to a cell aggrega- 
Figure 3.  Neurite outgrowth of dorsal  root ganglia neurons on 
NgCAM-expressing  CV-1 cells. DRG neurons cultured on CV-1 
cells were stained  with indirect  immunofluorescence  using anti- 
Fll antibodies.  NgCAM-expressing  CV-1 cells promote neurite 
outgrowth  (a).  The  presence  of polyclonal  anti-NgCAM  Fab 
strongly reduced neurite outgrowth (b), whereas the presence of 
polyclonal  anti-axonin-1  Fab  was  without  effect (c).  Parental 
CV-1 cells did not promote neurite outgrowth (d). Bar, 50 I~m. 
tion  assay.  Microscopic  inspection  revealed  that  only 
monocolored aggregates were formed (Fig. 4, i and k). The 
exclusion of axonin-l-expressing cells from aggregates of 
NgCAM-expressing  cells  and  the  exclusion  of NgCAM- 
expressing  cells  from  aggregates  of axonin-l-expressing 
cells was nearly complete. In > 100 aggregates of NgCAM- 
expressing cells, <10% contained an axonin-l-expressing 
cell and vice versa. Thus, a heterophilic NgCAM/axonin-1 
binding between molecules located on different cells was 
not formed. 
Several independent  pieces of evidence confirmed that 
axonin-1  and  NgCAM  expressed  heterologously  in  the 
myeloma cells  were  structurally  intact  and  functionally 
competent. Axonin-l-expressing myeloma cells were de- 
scribed in detail previously (Rader et al., 1993).  The solu- 
bilized  membrane  fraction  of  NgCAM-transfected  cells 
contained  recombinant  NgCAM  with  the  characteristic 
pattern of bands at 210/190,  140,  and 80 kD (Fig. 2 c), as 
described  for  wild-type  NgCAM  purified  from  chicken 
brain (Fig 2 a, Grumet et al., 1984) and chicken DRG neu- 
rons (Fig. 2 b). This band pattern had been demonstrated 
to originate from proteolytic cleavage of the molecule in 
the third FnIII domain, and it is thought to occur in the 
native conformation of the protein (Burgoon et al., 1991; 
Grumet, 1992). Indirect immunofluorescence staining dem- 
onstrated  that  recombinant  NgCAM  is  exposed  on  the 
surface of the myeloma cells (Fig. 4, a  and b). These Ng- 
Table L CV-1 Cells Expressing NgCAM Promote Neurite 
Outgrowth  from DRG Neurons 
Cell  Without Fab  Anti-ax- 1  Anti-Ng 
CV-1-NgCAM  34 --- 5  28 ±  4  6  ±  3 
CV-1 (parental)  2  ±  2  1 ±  I  7  ±  3 
DRG neurons were cultured on parental and NgCAM-expressing  CV-1 ceils in the ab- 
sence  and presence  of anti-axonin-1  or anti-NgCAM  Fab.  After 20 h,  the cultures 
were fixed and stained  for FI 1. In each condition,  100 neurons  were inspected.  The 
percentage  of neurons  with neurites  longer than two cell diameters was determined, 
The numbers given represent mean _+ SEM of three independent  experiments. 
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ated myeloma cell aggregation. NgCAM- 
expressing myeloma cells formed large ag- 
gregates  (a and b). Indirect immunofluo- 
rescence demonstrates  that NgCAM is ex- 
pressed on the cell surface (b). Aggregate 
formation was prevented by preincubation 
with anti-NgCAM Fab (c and d). Only Ng- 
CAM-expressing  cells participated in ag- 
gregates.  Parental  myeloma  cells  (red) 
were not included in the aggregates of Ng- 
CAM-expressing cells (e and f). NgCAM- 
expressing myeloma cells marked with red 
and green fluorescent dyes formed mixed 
aggregates (g and h). NgCAM-expressing 
(green) and axonin-1--expressing (red) my- 
eloma cells formed monocolored, but not 
mixed-colored,  cell aggregates  (i and k). 
Phase-contrast  (a, c, e, g, and i) and fluo- 
rescence photographs (b, d, f, h, and k). Bar, 
50 tun. 
CAM-expressing  myeloma cells formed aggregates  con- 
sisting of up to 50 cells. Aggregation was prevented by in- 
cubation with anti-NgCAM Fab (Fig. 4, c and d). To test 
whether the aggregation of the NgCAM-expressing cells 
was due to a heterophilic binding between NgCAM and an 
undetermined surface protein of the myeloma cells, we 
investigated  cell  aggregation  in  mixed  populations  of 
NgCAM-expressing  and  wild-type  myeloma  cells.  Ng- 
CAM-expressing myeloma cells were stained with a fluo- 
rescent intracellular dye and  mixed with  nontransfected 
cells stained  with a  different dye. Under  this  condition, 
only  NgCAM  transfectants  participated  in  aggregates, 
whereas  the  vast  majority of single  cells  were  parental 
J558L cells (Fig. 4, e and 3'). In contrast, different popula- 
tions  of NgCAM-expressing  ceils  formed  mixed  aggre- 
gates (Fig. 4, g and h). These results indicate that recombi- 
nant NgCAM  on the surface of myeloma cells mediates 
cell aggregation via homophilic binding across the inter- 
cellular space. 
NgCAM-expressing COS Cells Do Bind 
Axonin-l-Conjugated Covaspheres 
To test whether cell surface-expressed recombinant Ng- 
CAM  was  able  to  bind  axonin-1  presented  on  Cova- 
spheres rather than on the surface of a  cell, COS-7 cells 
were transiently transfected by electroporation with the 
expression  vector  pSCT-NgCAM.  Immunocytochemical 
staining  revealed  a  transfection  efficiency of  15%  and 
demonstrated that heterologously expressed NgCAM was 
exposed on the cell surface (Fig. 5). Analysis of membrane 
fractions by SDS-PAGE and immunoblotting showed that 
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nin-1--conjugated  Covaspheres  to  Ng- 
CAM-  and  axonin-1--expressing  COS 
cells. NgCAM-  and  axonin-l-expressing 
ceils were visualized by indirect immuno- 
fluorescence.  Covaspheres  conjugated 
with axonin-1 (b)  or NgCAM  (c) bound 
strongly to NgCAM-expressing cells. Axo- 
nin-l-expressing  cells  bound  Cova- 
spheres  conjugated  with NgCAM  poorly 
(d, see also Rader et al., 1996). Phase-con- 
trast  (a)  and  fluorescence  optics  (b-d). 
Bar, 25 p~m. 
transfected COS  cells produced NgCAM  with  the  same 
electrophoretic  band  pattern  as  brain-deriVed  NgCAM 
(Fig. 2 e). Cells expressing NgCAM were capable of bind- 
ing Covaspheres conjugated with axonin-1 (Fig. 5, a and b) 
and NgCAM (Fig. 5 c). This binding was abolished com- 
pletely after preincubation of the cells with anti-NgCAM 
Fab (data not shown). If the heterophilic interaction be- 
tween axonin-1 and NgCAM was studied in the reversed 
situation,  i.e., with axonin-1  presented on the surface of 
COS  cells  and  NgCAM  conjugated  to  Covaspheres,  a 
binding  was  observed  as  well.  However,  the  cells  with 
bound  Covaspheres represented a  relatively minor frac- 
tion of the axonin-l-expressing cells (Fig. 5 d). Quantifica- 
tion of the binding of Covaspheres to NgCAM-expressing 
cells revealed that 61  --- 3%  (mean  --- SD; n  =  3) of the 
cells bound NgCAM-Covaspheres and 53 --- 5% (n  =  5) 
bound axonin-l-Covaspheres. In contrast, only 15 _  6% 
(n  =  5) of the axonin-l-expressing cells bound NgCAM- 
Covaspheres. 
In  summary, the results of the COS  cell-Covaspheres 
binding studies demonstrated that membrane-bound Ng- 
CAM can engage in a heterophilic binding with axonin-1 
that  is  presented  in  the  Covaspheres-conjugated  form 
rather than on the surface of another cell. Intriguingly, a 
considerably weaker  binding  was  found  when  axonin-1 
was presented in the cell membrane-bound form and Ng- 
CAM  was  on  the  Covaspheres  (see  also  Rader  et  al., 
1996). 
Antibody-induced Capping of  NgCAM Results in 
Cocapping of  Axonin-1 
To test whether NgCAM and axonin-1 interact when they 
are present on the surface of the same cell, cocapping ex- 
periments were performed on CV-1 cells that were stably 
transfected with both NgCAM and axonin-1. These cells 
are well suited for such studies because of their large size 
and smooth surface. As shown by Western blot analysis 
(Fig 2, i and k), they expressed axonin-1 and NgCAM at a 
ratio of ~1:2.  For the cocapping assays, cells were incu- 
bated with monoclonal anti-NgCAM IgG. To induce cap- 
ping,  the  first  antibodies  were  cross-linked  with  rabbit 
anti-mouse  IgG.  After the capping  procedure, NgCAM 
exhibited a  patchy distribution in  >90%  of the cells,  as 
demonstrated by immunocytochemical staining with a Texas 
red-labeled donkey anti-rabbit antibody (Fig. 6 a). Stain- 
ing of axonin-1 with a FITC- labeled second antibody re- 
vealed a  striking colocalization of axonin-1  with NgCAM 
patches (Fig. 6 c). Possible cross talk between FITC and 
Texas red fluorescence was ruled out as an explanation 
for the colocalized fluorescence signal because, under the 
conditions  used,  patches  labeled  with  only  one  fluoro- 
chrome did not elicit a signal detectable with the filter set 
for the other fluorochrome. Axonin-1 colocalized with al- 
most  all  of the  NgCAM  patches  on  NgCAM-capped 
cells. In rare instances, however, clusters composed exclu- 
sively of axonin-1 were observed. No capping and cocap- 
ping was observed when the primary antibody was omitted 
(Fig. 6, b and d). Cocapping of axonin-1 and NgCAM was 
also found when capping was induced with a monoclonal 
anti-axonin-1  IgG.  However,  clusters  exclusively  com- 
posed  of  the  antibody-capped  molecule,  i.e.,  axonin-1, 
were  more  frequent  than  when  anti-NgCAM  IgG  was 
used for capping, and randomly distributed NgCAM that 
had not accompanied axonin-1 into clusters was relatively 
abundant in this situation. A  possible explanation for this 
observation may be that the force pulling NgCAM along 
with the capping axonin-1 molecule as a  result of a cis- 
interaction may be opposed by contact of the cytoplasmic 
domain with cytoskeletal components (see Davis and Ben- 
nett, 1994). 
Heterodimeric Complexes of  Axonin-I and NgCAM 
Are Detected by Chemical Cross-linking 
For the confirmation of a direct molecular interaction (cis- 
interaction) of axonin-1 with NgCAM in the membrane of 
intact neurons, chemical cross-linking was performed with 
dissociated DRG neurons. To minimize cell-cell contacts, 
the cells were cultured at low density (Fig. 7 d). The homo- 
bifunctional  cross-linking  reagent  DST  was  chosen  be- 
cause of its short spacer, to obtain a high degree of selec- 
tivity.  During  the  cross-linking  procedure,  no  obvious 
morphological changes of the cultures were observed. At 
the end of the reaction, membrane proteins were extracted 
from the cells with detergent, and axonin-1 was immuno- 
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nin-1 with  NgCAM  on CV-1 
cells. Capping of NgCAM was 
induced  with  a  monoclonal 
anti-NgCAM  antibody  and 
rabbit  anti-mouse  IgG.  Ng- 
CAM caps were  visualized by 
immunofluorescence  staining 
using Texas red-labeled  don- 
key  anti-rabbit  IgG  (a). Co- 
capping of axonin-1 with Ng- 
CAM  was  determined  using 
goat  anti-axonin-1  Fab  and 
FITC-labeled  donkey  anti- 
goat IgG (c). For a control, the 
mAb  against  NgCAM  was 
omitted (b and d). For inspec- 
tion of the cells, a confocal mi- 
croscope was used.  (a  and  b) 
Texas red filter set. (c and d) 
FITC filter set. Bar, 10 Ixm. 
precipitated, separated by SDS-PAGE, and blotted onto 
nitrocellulose.  Immunochemical detection localized  axo- 
nin-1 in the monomeric form (125 kD) and additionally in 
a band with an apparent molecular mass of 260 kD (Fig. 7 a). 
In the analysis of the 260-kD component by serial immuno- 
detection  with  anti-axonin-1,  anti-NgCAM,  and  anti- 
NrCAM antibodies on the same nitrocellulose, NgCAM, 
but not NrCAM, was found (Fig. 7, b and c, respectively). 
Superposition of the chemiluminescence images allowed a 
precise colocalization of the NgCAM signal with the axo- 
nin-1  signal.  Thus,  the  260-kD  component represents  a 
heterodimeric complex consisting of axonin-1 and the ex- 
Figure 7.  Chemical cross-linking of NgCAM and axonin-1 on in- 
tact DRG neurons. Dissociated DRG neurons were cultivated at 
low density on laminin for 15 h (d). Cross-linking was performed 
with 1 mM DST. The reaction  was stopped  after 0, 20, and 60 
min. Axonin-1 and complexes containing axonin-1 were immuno- 
precipitated with a monoclonal anti-axonin-1 antibody, subjected 
to SDS-PAGE, and transferred  to nitrocellulose. The nitrocellu- 
lose was probed serially with anti-axonin-1,  anti-NgCAM, and 
anti-NrCAM antibody using enhanced chemiluminescence detec- 
tion. Axonin-1 appeared  as a monomer (125 kD) and as a cross- 
linked product (band at 260 kD), as visualized by anti-axonin-1 
staining (a). The 260-kD band contained NgCAM cross-linked to 
axonin-1 (b). The 260-kD band does not contain NrCAM (c). 
tracellular fragment of NgCAM with their apparent mo- 
lecular masses of 125 and 140 kD, respectively. 
Antisense Oligonucleotide-mediated Suppression of 
Axonin-I Translation Prevents Neurite Outgrowth on 
NgCAM Substratum 
To investigate  the role of the cis-interaction  of axonin-1 
and NgCAM in neurite outgrowth, we suppressed the ex- 
pression of axonin-1 in dissociated DRG neurons by anti- 
sense  oligonucleotides.  A  combination of two  antisense 
oligonucleotides complementary to the regions comprising 
the  translation  initiation  site  and  the  translation  stop 
codon, respectively, were used. The corresponding sense 
oligonucleotides served as  controls.  After application  of 
the oligonucleotides, the neurons were counted and plated 
onto NgCAM- or laminin-coated culture dishes. Immuno- 
cytochemistry for the  neuronal marker Fll  was used  to 
distinguish neurons from nonneuronal cells, and with Try- 
pan blue dye exclusion, we identified live cells. After 15 h 
in culture, the effects of the antisense treatment were in- 
vestigated by cell counts, Western blot analysis, and an as- 
sessment of neurite outgrowth using the method described 
by Chang et al. (1987). When counted 4 h after plating, the 
antisense  oligonucleotide-treated cultures  of dissociated 
DRG  cultures  revealed  a  reduction  in  the  plating  effi- 
ciency of :,-15% on NgCAM substratum, whereas on lami- 
nin,  the  cultures  treated  with  antisense  oligonucleotides 
had the  same plating  efficiency as  the  sense  oligonucle- 
otide-treated cultures. 
Immunoblot analysis of cultures grown on laminin for 
15 h  showed that axonin-1 antisense oligonucleotides re- 
duced the total amount of axonin-1 by ~-,95 %  compared 
with sense oligonucleotide-treated cultures (Fig. 8 a). Re- 
lated neural cell adhesion molecules, such as Fll and Ng- 
CAM, were only slightly reduced in the antisense oligonu- 
cleotide-treated  cells.  Therefore, we  concluded that  the 
antisense oligonucleotide treatment specifically  and almost 
completely suppressed the translation of axonin-1. 
When inspected 15 h after plating, no difference in neu- 
rite outgrowth on laminin was observed between the anti- 
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Figure 8.  Suppression of ax- 
onin-1  translation  by  anti- 
sense  oligonucleotides.  (a) 
Western  blot  analysis  of 
DRG  cultures  on  laminin 
substratum using chemilumi- 
niscence detection. Densito- 
metric analyses were carded 
out with triplicate blots of in- 
dependent  experiments. 
Densitometric results of the 
sense oligonucleotide--treated 
cultures are given as  100%. 
Mean and SD are given. Ax- 
onin-1 expression was strongly 
reduced in  antisense-treated 
cultures,  whereas  Fll  and 
NgCAM expression was only 
slightly affected. (b) Quanti- 
fication of neurite formation 
in cultures treated with anti- 
sense  and  sense  oligonucle- 
otides  and  plated on  either 
NgCAM or laminin substra- 
tum.  Neurites  were  defined 
as processes that extend from 
the neuronal soma by a  dis- 
tance  longer  than  20  I~m. 
Each  condition  was  carried 
out in triplicate, and at least 
150  neurons  were  counted 
for  each  experiment.  Mean 
and SD are given.  (c) Mea- 
surements of neurite lengths 
and determination of the me- 
dian  values  of  the  neurite 
lengths (NLs0). Processes ex- 
tending from  the  cell soma 
for a distance longer than 20 
ixm were defined as neurites. 
For  each  cell,  the  longest 
neurite  was  measured,  and 
measurements of at least 80 
cells with neurites were plotted as percentage of neurons with neurites longer than a given length (y-axis) vs the neurite length (x-axis), 
as introduced by Chang et al. (1987). The neurite length reached by 50% of the neurites (NL50) was determined as the median neurite 
length. The example presented shows measurements obtained with one pair of sense and antisense oligonucleotide-treated  cultures 
on NgCAM substratum. (Filled squares) Cultures treated with antisense oligonucleotides. (Open circles) Cultures treated with sense oli- 
gonueleotides. (d) Median values of neurite lengths (NL50) in cultures treated with antisense and sense oligonucleotides and plated on 
either NgCAM or laminin substratum. Each NLs0 value represents the mean and the SD of four independent cultures on NgCAM and 
three cultures on laminin. In the cultures on NgCAM substratum, 79-138 neurites were measured, while in the cultures on laminin, 36- 
76 neurites were measured. 
sense and the sense oligonucleotide-treated cultures (Fig. 
8 b). Under both conditions, ,--~70% of the neurons devel- 
oped neurites.  On NgCAM substratum, 52%  of the neu- 
rons  of the  sense  oligonucleotide-treated cultures devel- 
oped neurites. In contrast, only 34%  of the neurons of the 
antisense  oligonucleotide-treated  cultures  had  neurites. 
The  neurite  lengths  in  sense  and  antisense  oligonucle- 
otide-treatcd cultures were measured on NgCAM and on 
laminin (Fig. 8, c and d). Of each condition, triplicate cul- 
tures were made and the results of each culture were plot- 
ted separately (e.g., see Fig. 8  c). From each culture, the 
median  value  of the  neurite  lengths  (NLs0)  was  deter- 
mined as the neurite length developed by 50% of the neu- 
rite-bearing neurons (NLs0). In Fig. 8 d, the means of the 
NLs0 values, as determined from triplicates of each condi- 
tion, are shown.  On  laminin, no significant difference in 
the median neurite lengths in cultures treated with sense 
or antisense oligonucleotides were found. In contrast, the 
median neurite length on NgCAM substratum was mark- 
edly reduced in the cultures treated with antisense oligo- 
nucleotides; in the cultures treated with sense oligonucle- 
otides, the mean NLs0 value was 97  ~m, whereas a  mean 
NLs0 of 56 ~m was measured in antisense cultures. 
Comparison  of the  neurite  length  distributions in  the 
sense  and  antisense  oligonucleotide-treated cultures  on 
NgCAM (Fig. 8 c) revealed a remakable left-shift over the 
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otide-treated  cultures.  In  contrast,  in  the  region  of the 
longest neurites,  the curves were almost superimposable. 
Approximately  10%  of the  neurons  had  neurites  longer 
than 300 ~m, regardless whether the cultures were treated 
with  sense  or antisense  oligonucleotides  (Fig.  8  c).  One 
possible explanation for this observation was that the long 
neurites  in the antisense  oligonucleotide-treated  cultures 
were  derived  from neurons  that  had  resisted  oligonucle- 
otide-mediated suppression of axonin-1 completely. Thus, 
we carried out immunocytochemical staining for axonin-1 
at the end of the experiments and determined the percent- 
age of neurites  with  detectable  axonin-1.  The results  are 
presented in Fig. 9 e. On a laminin substratum, the number 
of neurons with neurites carrying axonin-1 on their surface 
was N14%  of the total number of the neurons with neu- 
rites (for an illustration, see Fig. 9, c and d). This result in- 
dicates that synthesis of axonin-1 was efficiently inhibited 
in the major proportion of neurons by the combination of 
antisense  oligonucleotides  used.  In contrast,  in  the  anti- 
sense  oligonucleotide-treated  cultures  on  NgCAM  sub- 
stratum,  almost  all  neurites  exhibited  axonin-1  on  their 
surface. Together, these results  indicate that on NgCAM 
substratum  only neurons  expressing  axonin-1  were capa- 
ble  of developing  neurites,  whereas  neurons  on  laminin 
developed  neurites  regardless  whether  or  not  they  ex- 
pressed axonin-1. 
When analyzed with regard to quantitative  aspects, we 
found that on laminin  substratum,  ~14%  of the neurites 
exhibited  axonin-1  on their surface. Because, on laminin, 
~70%  of the  neurons  made  neurites,  and  assuming that 
the  proportion  of  axonin-l-expressing  cells  among  the 
neurons without neurites  was approximately equal to the 
proportion found among neurons  with  neurites,  we con- 
cluded  that  antisense  oligonucleotide treatment  was par- 
tially or completely ineffective in ~20% of all neurons. In 
contrast, on NgCAM substratum, >90% of the neurites of 
antisense-treated cultures exhibited immunodetectable axo- 
nin-1  on their  surface.  Since,  in this  experimental  condi- 
tion, ~34% of the neurons produced neurites, N1.5 times 
as  many  neurons  with  axonin-l-bearing  neurites  than 
those  in  antisense  oligonucleotide-treated  cultures  on 
laminin were observed. 
An explanation  for this  apparent  discrepancy  may be 
that the axonin-l-bearing neurites  in the antisense  oligo- 
nucleotide-treated cultures on NgCAM are not only found 
on neurons that are capable of synthesizing new axonin-1. 
Short neurites  may also be formed with residual axonin-1 
from the neuronal soma. As expected in consideration of 
a  relatively  slow  turnover  of axonin-1  with  a  half-life of 
>100 h  in dissociated DRG cultures  (Ruegg et al.,  1989b), 
we  found  indeed  that  axonin-1  was  not  reduced  on  the 
neuronal  somas of antisense  oligonucleotide-treated  cul- 
tures (Fig. 9 b). It is thus conceivable that residual axonin-1 
of the neuronal somas can deliver a  critical concentration 
of axonin-1  to forming neurites  by anterograde  diffusion. 
However, in the absence of axonin-1 synthesis, the supply 
of axonin-1 to the forming neurite is limited by the initial 
content  of the  cell  soma.  Diffusional  spread  of axonin-1 
into newly formed neurites results in a decrease of the ax- 
onin-1 concentration per unit of membrane area. Eventu- 
ally,  the  axonin-1  concentration  will  fall  below  a  given 
threshold value necessary to support neurite  growth, and 
neurite  growth will stop. The markedly  weaker  axonin-1 
staining of the somas of antisense oligonucleotide-treated 
neurons on laminin  (Fig.  9  d), where the median neurite 
length was approximately three times as long as that in the 
antisense  oligonucleotide-treated  cultures  on  NgCAM, 
may be interpreted  as evidence for a thinning out of axo- 
nin-1  by  diffusional  spreading  from  the  neuronal  soma 
into  newly formed  membrane  that  accompanies  neurite 
elongation. 
Residual  axonin-1  of the  cell somas cannot be  consid- 
ered  as the  source of the axonin-1  found on longer neu- 
rites.  As evident in antisense  oligonucleotide-treated  cul- 
tures  on  laminin,  residual  axonin-1  from  the  cell  soma 
cannot  invade  longer  neurites  in  detectable  concentra- 
tions. Thus, axonin-1 on the long neurites in the antisense 
oligonucleotide-treated  cultures on NgCAM must be de- 
rived from continued protein synthesis while the neurites 
were growing.  In support  of this  conclusion, we have re- 
cently found that axonin-1 on growth cones of long DRG 
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Figure  9.  Morphological and 
immunocytochemical  analy- 
sis  of  antisense  oligonucle- 
otide-treated DRG cultures. 
Ceils  treated  with  antisense 
oligonucleotides  were  cul- 
tured  on NgCAM (a and b) 
or laminin (c and d). After 15 
h the cells were stained with 
anti-axonin-1.  Over 90%  of 
the neurites on NgCAM sub- 
stratum stained for axonin-1 
(a and b). Antisense oligonu- 
cleotide-treated  DRG  neu- 
rons  grew  on  laminin  sub- 
stratum  regardless  whether 
or not they expressed axonin-1 (c and d). Phase-contrast (a and c) and fluorescence optics (b and d). Bar, 75 i~m. (e) Immunocytochem- 
ical staining of neurites for axonin-1. On NgCAM, ~90% of the neurites stained for axonin-1 regardless whether the cultures had been 
treated with sense or antisense oligonucleotides. On laminin,  ,'~95  % of the neurites of the sense oligonucleotide-treated cultures stained 
for axonin-1, whereas in antisense  oligonucleotide-treated cultures, only ~14% of the cells were axonin-1  positive.  Each value repre- 
sents the mean and the SD of triplicate cultures. In each culture, at least 60 neurites were evaluated. 
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directly inserted into the growth cone membrane (Vogt 
et al., 1996). Thus, long neurites have to be interpreted as 
neurites  of  neurons  that  had  resisted  oligonucleotide- 
mediated suppression of axonin-1 translation. 
In summary, the quantitative considerations of the oli- 
gonucleotide inhibition experiments, together with the im- 
munocytochemical stainings  of the neurites, suggest that 
the neurite length distribution curve of the antisense oligo- 
nucleotide-treated cultures on NgCAM is composed of three 
segments,  (a)  a  segment  with long neurites  (>300  t~m) 
most likely formed by neurons in which the antisense oli- 
gonucleotide treatment was completely ineffective; (b) a 
segment including neurites with reduced neurite lengths, 
comprising neurites of neurons in which the antisense oli- 
gonucleotide treatment had reduced but not completely 
suppressed  the  axonin-1  expression  (middle  segment  of 
curve); and (c) a segment with short neurites, which could 
be formed without de novo synthesis of axonin-1, using re- 
sidual axonin-1 of the neuronal soma (approximately one- 
third of the neurites). A  common feature of virtually all 
neurites observed on NgCAM  substratum  was that they 
exhibit axonin-1 on the surface. Thus, we conclude that 
without axonin-1, DRG neurites cannot be formed on an 
NgCAM substratum. 
Discussion 
Cocapping and chemical cross-linking demonstrated that 
the cell surface molecules axonin-1 and NgCAM interact 
in the plane of the neuronal membrane. The suppression 
of axonin-1 translation by antisense oligonucleotides ren- 
dered chicken DRG neurons incapable of extending neu- 
rites on an NgCAM substratum. These results suggest that 
neurite outgrowth from DRG neurons on NgCAM  sub- 
stratum  requires  the  formation of an  NgCAM/axonin-1 
heterodimers in the growth cone membrane in addition to 
the established homophilic trans-interaction between growth 
cone NgCAM  and substratum NgCAM  (Lemmon et al., 
1989). 
NgCAM and Axonin-I Form Heterodimers  in the Plane 
of the Neuronal Membrane 
Speculations on the possibility that an interaction between 
NgCAM and axonin-1 may occur in the plane of the neu- 
ronal membrane found a structural basis in results of a re- 
cent study in which the NgCAM-binding site of axonin-1 
was  mapped  (Rader et al.,  1996). Domain deletion mu- 
tants and EM pictures of soluble wild-type axonin-1 were 
used as a basis for the proposal of a structural model of 
membrane-anchored axonin-1 in which the NH2-terminal 
moiety of the molecule (containing the NgCAM-binding 
conglomerate composed of the Ig domains 1-4) was bent 
backwards  toward  the  membrane  in  a  horseshoe-like 
form.  The  localization  of the  NgCAM-binding  domain 
conglomerate close to the membrane favored the idea that 
binding with an NgCAM of the same membrane might be 
more likely established than binding with an NgCAM of 
another cell. In the work presented here, we investigated 
whether axonin-1 and NgCAM are associated in the plane 
of the same membrane by two independent approaches, 
namely antibody-induced capping/cocapping and chemical 
cross-linking.  Antibody-induced capping of NgCAM  re- 
suited in extensive cocapping of axonin-1. Since axonin-1 
is glycosylphosphatidylinositol (GPI)-anchored to the cell 
membrane, it is localized exclusively extracellularly. There- 
fore, we considered a direct binding between the extracel- 
lular segment of NgCAM and axonin-1 as the most likely 
explanation. However, an association mediated by a linker 
protein could not be excluded. Thus, cross-linking studies 
with low density cultures of dissociated neurons were car- 
ried out. DRG neurons express both NgCAM and axonin-1 
on their growth cones, axons, and cell somas (Kuhn et al., 
199t; Stoeckli et al., 1996). Using a short bifunctional reagent, 
we found axonin-1 and NgCAM in an SDS- and 13-mercap- 
toethanol-stable  complex  with  an  apparent  molecular 
mass  of 260 kD. The size of this complex corresponded 
closely to the sum of the molecular masses of axonin-1 and 
the  140-kD  extracellular  fragment  of NgCAM.  Known 
ligands of NgCAM and axonin-1, such as Fll (Brtimmen- 
dorf et al., 1993) and NrCAM (Suter et al., 1995), respec- 
tively, were not found in this complex. Since cultures were 
grown on a  laminin  substratum  in  low density and  col- 
lected before contacts between neurites occurred, encoun- 
ters between NgCAM and axonin-1 were possible only in 
the plane of the neuronal membrane. Hence, these results 
demonstrated  unequivocally that  NgCAM  and  axonin-1 
bind each other selectively in the plane of the neuronal 
membrane (cis-binding). 
NgCAM and Axonin-1 on Different Myeloma Cells Are 
Not Capable of Mediating  CeU-CeU Aggregation 
The results of binding studies with myeloma cells express- 
ing axonin-1 or NgCAM indicated that NgCAM and axo- 
nin-1  are  not  capable  of mediating  cell  aggregation  by 
binding each other across the extracellular space (trans- 
binding). Interestingly, TAG-1 (Furley et al., 1990) and L1 
(Moos et al., 1988), the presumptive rodent homologues of 
axonin-1 and NgCAM, respectively, were also reported to 
be unable to mediate cell aggregation when expressed in 
Drosophila Schneider 2 cells (Felsenfeld et al., 1994). The 
lack of binding between NgCAM and axonin-1 expressed 
by myeloma cells cannot be explained as a deficiency of 
the recombinant proteins since both recombinant NgCAM 
and  axonin-1  were  structurally  intact  and  functionally 
competent. 
In contrast with studies involving NgCAM and axonin-1 
exposed on the  surface of different cells, a  heterophilic 
NgCAM/axonin-1 interaction was established when one of 
the  two  proteins  was  presented  on  Covaspheres  rather 
than  on the  surface of cells.  Recombinant  NgCAM  ex- 
pressed on the surface of COS cells was capable of binding 
axonin-1 (either wild-type or recombinant) when axonin-1 
was presented on Covaspheres. Interestingly, NgCAM/ax- 
onin-1  binding in the reversed situation, when recombi- 
nant axonin-1 was expressed on the surface of COS cells 
and  NgCAM  was  on  Covaspheres,  was  considerably 
weaker. This result is in line with the notion that cell sur- 
face-bound axonin-1 is in a conformation and orientation 
that  is  unfavorable for  NgCAM  binding  (Rader  et  al., 
1996). Studies on the NgCAM-binding domain of axonin-1 
had revealed a horseshoe-shaped structure of axonin-1 in 
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erate of the four amino-terminal Ig domains) was oriented 
toward the  membrane  that  restricted its accessibility for 
macromolecules residing on  the  surface  of another  cell. 
Based  on  these  results, we  propose  that  axonin-l-Cova- 
spheres bind to NgCAM-expressing cells better than Ng- 
CAM-Covaspheres bind to axonin-l-expressing cells, be- 
cause  at  least  a  fraction  of  the  axonin-1  molecules  on 
Covaspheres is bound in an orientation and conformation 
appropriate  for  binding  cell  surface-exposed  NgCAM, 
whereas membrane-anchored  axonin-1 is present only in 
one  (unfavorable)  form.  We  suggest that  the fraction  of 
axonin-1 molecules on the Covaspheres that become en- 
gaged  in  a  binding with  membrane-bound  NgCAM  are 
oriented on the beads such that they approach NgCAM in 
the same relative orientation as an axonin-1 bound to the 
same membrane. 
NgCAMIAxonin-1 Trans-Binding Is Not Required 
for Neurite Outgrowth on NgCAM Substratum, but 
Neurite Outgrowth Mediated by NgCAM Receptor 
Requires a Cooperation with Axonin-1 in the 
Neurite Membrane 
Our observation that  a  heterophilic trans-interaction  be- 
tween  axonin-1  and  NgCAM  expressed in  different my- 
eloma cells was not formed is in line with the observations 
that anti-axonin-1 antibodies did not perturb outgrowth of 
DRG neurons on NgCAM adsorbed to tissue-culture plas- 
tic (Kuhn et al., 1991; Stoeckli et al., 1996) or on NgCAM 
expressed  on  the surface of CV-1  cells (this paper). To- 
gether, these results support the hypothesis that in growth 
cones growing on an NgCAM substratum, only NgCAM, 
but not axonin-1, is required for substratum contact. How- 
ever, axonin-1 is required in the growth cones for neurite 
outgrowth  on NgCAM substratum.  When we suppressed 
the translation of axonin-1 in DRG  neurons  and thus its 
insertion into the growth cone membrane, we found that 
neurite outgrowth on NgCAM substratum was strongly re- 
duced. In contrast, on laminin substratum, on which neu- 
rite outgrowth  occurs by a  mechanism involving integrin 
receptors  (Tomaselli et  al.,  1986),  a  lack of axonin-1  in 
growth cones did not affect neurite outgrowth. These re- 
sults implicate axonin-1 of the growth cone as a cofactor in 
the promotion of neurite outgrowth on NgCAM substra- 
tum, acting through a c/s-binding with growth cone NgCAM 
without being involved in a binding with the substratum. 
The function of axonin-1 via a  c/s-interaction with Ng- 
CAM, rather than  a  trans-interacion  with a  ligand in the 
substratum,  could  explain why  neurite  outgrowth  on  an 
NgCAM substratum was not affected by anti-axonin-1 an- 
tibodies. Although we do not understand in detail the con- 
Figure 10.  Molecular models for neurite outgrowth promotion 
mediated by interactions of NgCAM and axonin-1. (a) In the ab- 
sence of axonin-1, when  only a trans-binding contact with sub- 
stratum NgCAM is established, growth cone NgCAM is in a non- 
signaling state and no neurite outgrowth is observed. (b and c) In 
the presence of axonin-1 on growth cones, growth cone NgCAM 
establishes a c/s-binding with growth cone axonin-1 in addition to 
the trans-binding with substratum NgCAM. In this case, neurite 
outgrowth is activated. Results demonstrating an interaction be- 
~on  () 
b  Dual  Activation Model 
() 
c  Signal Cooperation Model 
tween NgCAM and axonin-1 in the plane of the neuronal mem- 
brane are in accordance with the recently determined domain or- 
ganization of axonin-1, indicating that the Ig and FnlII domains 
of axonin-1 are arranged in a horseshoe-like form and that the 
NgCAM-binding site of axonin-i is located on a conglomerate of 
the four amino-terminal Ig domains (Rader et al., 1996). As a re- 
sult of the horseshoe-like form of axonin-1, the NgCAM-binding 
site is located in the proximity of the membrane. In this confor- 
mation, a binding to NgCAM of the same membrane rather than 
to NgCAM of another cell may be favored. Alternative models 
for an activation of neurite outgrowth on NgCAM substratum 
are conceivable. In both mechanisms proposed, a trans-binding of 
growth cone NgCAM to substratum NgCAM combined with a 
c/s-binding to axonin-1 in the plane of the growth cone mem- 
brane is required. In the Dual Activation Model (b), a  neurite 
outgrowth  signal is emitted only from  NgCAM.  An activated 
form of NgCAM (asterisk) results from a combination of a trans- 
binding with substratum NgCAM and a cis-binding with growth 
cone axonin-1. In the Signal Cooperation Model (c), both Ng- 
CAM and axonin-1 emit signals. As a result of its binding to the 
substratum growth cone, NgCAM is concentrated in the substra- 
tum-apposed growth cone membrane. The c/s-binding of axonin-1 
in turn results in a concomitant accumulation of axonin-1. Thus, 
two initially independent signals are concentrated and brought 
into proximity in the substratum-facing area of the growth cone 
and thus may cooperate to generate a neurite outgrowth-promot- 
ing signal. 
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and their corresponding antibodies in  a  reaction with  a 
polyclonal Fab,  it is conceivable that  a  trans-interaction 
may be  more  susceptible  to  perturbation  by antibodies 
than a cis-interaction.  In support of this speculation, one 
could argue that binding sites of trans-interactions  may be 
more accessible for antibodies than binding sites for c/s- 
interactions, which may be buried in the interior of the 
membrane. 
Binding studies with myeloma or COS cells expressing 
NgCAM have demonstrated that NgCAM alone can me- 
diate  cell-ceU  or  cell-Covaspheres  binding  by  its  ho- 
mophilic-binding capability. These results do not contra- 
dict  the  observation  that  axonin-1  is  required  for  the 
outgrowth of neurites from DRG neurons on an NgCAM 
substratum, as concluded from the experiments with the 
antisense oligonucleotides. Results of studies of the mech- 
anisms of neurite outgrowth on a variety of substrata indi- 
cate that binding between growth cone surface receptors 
and substratum components is not sufficient, but that the 
generation of additional intracellular signals is required. 
Studies by Doherty and co-workers have shown that neu- 
rite outgrowth mediated  by L1  depends  on Ca  2÷  influx 
(Williams et al.,  1992), as well as phosphorylation by an 
erbstatin analogue-sensitive tyrosine kinase (Williams et al., 
1994a). Recent evidence also implicates an activation of 
the  FGF receptor in  the  signaling  pathway underlying 
Ll-mediated neurite  outgrowth  (Williams  et  al.,  1994b; 
Doherty et al.,  1995).  Maness  and co-workers have pre- 
sented results from studies on src-/src- mice implicating 
the nonreceptor tyrosine kinase src in the transduction of 
Ll-dependent  neurite  outgrowth  (Ignelzi  et  al.,  1994). 
Moreover, Lemmon and co-workers have demonstrated 
that L1 signaling may be accompanied by a phosphoryla- 
tion of the intracellular domain of L1 by a casein kinase II 
(Wong et al., 1996). In the experimental system used here, 
the homophilic interaction of receptor NgCAM with sub- 
stratum  NgCAM  is  not  sufficient to  elicit  neurite  out- 
growth. The results presented suggest that axonin-1 may be 
one element required in addition to NgCAM for neurite 
outgrowth of DRG neurons on an NgCAM substratum. 
The generation of a neurite outgrowth signal upon es- 
tablishment of NgCAM/axonin-1 complexes may be achieved 
via different mechanisms (Fig. 10).  NgCAM may exist in 
two conformations, one signaling  and  one nonsignaling. 
NgCAM  without  a  cis-interaction  with  axonin-1  is  in  a 
nonsignaling state (Fig. 10 a). Transition to the signaling 
state occurs by a  combination of a  trans-binding  to the 
substratum and a c/s-binding to axonin-1 (dual activation 
model). In this model, axonin-1 would not transduce a sig- 
nal on its own but rather modulate the signal transduction 
of NgCAM (Fig. 10 b). Alternatively, it is conceivable that 
axonin-1 contributes an independent intracellular signal. 
As a GPI-anchored glycoprotein, axonin-1 might be capa- 
ble  of transmembrane  signaling by direct or lipid-medi- 
ated  interaction  with  a  putative  transmembrane  linker 
protein. Such linkers have been suggested to relay the sig- 
nal derived from GPI-anchored molecules to intracellular 
nonreceptor  tyrosine  kinases  (for  a  recent  review  see 
Brown, 1993). Recent evidence indicates that F11 (contac- 
tin) (Ranscht, 1988; Brtimmendorf et al., 1989), the closest 
relative of axonin-1,  is  linked  to fyn, a  nonreceptor ty- 
rosine kinase of the src family (Zisch et al., 1995). It is con- 
ceivable that the c/s-interaction of axonin-1 and NgCAM 
is required to bring the signaling complexes of NgCAM and 
axonin-1 into proximity so that they can interact to generate 
a novel signal distinct from the signals evoked by monomeric 
NgCAM and axonin-1 (signal cooperation model; Fig. 10 c). 
Conclusion 
Evidence from experiments described in this paper sug- 
gests  that  the  NgCAM-mediated  neurite  outgrowth  of 
DRG neurons depends crucially on a cooperation of Ng- 
CAM with axonin-1 that is implemented by the formation 
of  NgCAM/axonin-1  heterodimers  in  the  plane  of the 
growth cone membrane. Hence, an activation of neurite 
outgrowth on an NgCAM substratum depends on two in- 
teractions of growth cone NgCAM  that  are  both indis- 
pensable for a  neurite outgrowth signal:  one interaction 
with substratum NgCAM  (trans-interaction)  and one in- 
teraction with axonin-1 residing in the growth cone mem- 
brane (c/s-interaction). 
The fact that axonin-1 is spatially more restricted than 
NgCAM  during  neural  development speaks  against  the 
general applicability of the dual activation model where 
NgCAM  receptor  function  requires  axonin-1  as  a  c/s- 
bound activator in addition to substratum contact. How- 
ever, it is conceivable that some isoforms of NgCAM are 
capable of stimulating neurite outgrowth independent of 
cis-ligand activation. Alternatively, other regulators could 
replace axonin-1 in areas where it is not expressed. For in- 
stance, the FGF receptor has been implicated as a proxi- 
mal component of the Ll-signaling pathway (Williams et al., 
1994b). Fll(contactin) (Ranscht, 1988; Brtimmendorf et al., 
1989),  the  closest  relative  of axonin-1,  which  has  been 
demonstrated to bind  to NgCAM  (Briimmendorf et al., 
1993)  and exhibits an expression pattern clearly distinct 
from that of axonin-1, might be a possible candidate mole- 
cule for another c/s-activator of NgCAM. 
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